Houlihan Lokey, a global investment bank, hired Jonathan Guskind as a managing director in its healthcare group covering medical technology. He will be based in New York.
Guskind joined Houlihan Lokey from Morgan Stanley, where he spent more than a decade and most recently helped lead the medical technology coverage effort within the company’s healthcare investment banking group. Prior to Morgan Stanley, he worked in BNP Paribas’ leveraged and acquisition finance group.
“We are thrilled that Jonathan has joined us to further expand our medical technology practice in healthcare. His deep expertise and insights in the medical technology space are reflected by his outstanding track record of successful outcomes for clients on a broad range of M&A and capital raising transactions, and we are confident he will continue that success here,” Mark Francis, global head of the healthcare group at Houlihan Lokey, said. “Following our other recent additions to the team, Houlihan Lokey now has one of the largest global medtech-focused teams in financial services.”
Guskind’s hire closely follows the addition of five professionals to Houlihan Lokey’s healthcare team in London earlier this month, including Paul Tomasic as head of European healthcare and Andrew Murray-Lyon as director, as well as the appointments of Keith Barry as head of medical technology in September 2020 and Christian Lunny as managing director in April 2020. With these additions, Houlihan Lokey now has five senior professionals covering medical technology in New York, London, San Francisco and Sydney.
“As M&A activity in the medtech sector, particularly cross-border M&A, continues to increase, it is imperative that we are able to advise our clients around the world with a truly global team,” Barry said. “Today, we are better-positioned than ever to ensure superior outcomes for our medtech clients, and we’re delighted that Jonathan has joined us in that effort.”
“Houlihan Lokey’s market leadership in M&A and capital markets, its corporate culture and its clear commitment to build a world-class medtech coverage practice for its clients make for an exciting opportunity. I am excited to join the team, and I look forward to working with Keith, Paul, Christian, Andrew and the rest of the healthcare group to deliver on that commitment to our clients,” Guskind said.
